Evidence mapPaperPMID 35904170Full record

ReviewInternational journal of molecular medicine2022

The metabolic and molecular mechanisms of α‑mangostin in cardiometabolic disorders (Review).

Oliver Dean John, Annals Tatenda Mushunje, Noumie Surugau, Rhanye Mac Guad

Open access · hybridAbstract readReview
In one paragraph

Review in International journal of molecular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
5.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Aqueous Extract ofVeterinary sciences · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. [Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026
    Article
  6. Review
  7. Endothelial-Protective Actions of Diethylether Extract fromInternational journal of molecular sciences · 2025
    Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Investigating the Chemical Composition ofFoods (Basel, Switzerland) · 2023
    Article
  13. Demethylcalabaxanthone fromAntioxidants (Basel, Switzerland) · 2023
    Article
  14. Article
  15. Sitosterol-rich3 Biotech · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Oliver Dean JohnFaculty of Science and Natural Resources, Universiti Malaysia Sabah, 88400 Kota Kinabalu, Sabah, Malaysia.
Annals Tatenda MushunjeFaculty of Science, Asia‑Pacific International University, Muak Lek, Saraburi 18180, Thailand.
Noumie SurugauFaculty of Science and Natural Resources, Universiti Malaysia Sabah, 88400 Kota Kinabalu, Sabah, Malaysia.
Rhanye Mac GuadFaculty of Medicine and Health Sciences, Universiti Malaysia Sabah, 88400 Kota Kinabalu, Sabah, Malaysia.
Universiti of Malaysia Sabah · MYAsia Pacific International University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

α‑mangostin is a xanthone predominantly encountered in

Indexed as

Cardiovascular DiseasesXanthonesAnti-Inflammatory AgentsAntioxidantsFibrosisHumansHypoglycemic AgentsObesityPhosphatidylinositol 3-KinasesPPAR gammaSirtuin 1Anti-Inflammatory AgentsAntioxidantsHypoglycemic AgentsmangostinPhosphatidylinositol 3-KinasesPPAR gammaSirtuin 1XanthonesGarcinia mangostanametabolic syndromemetabolismobesityxanthoneα-mangostin

Identifiers

PMID35904170
PMCPMC9354700
OpenAlexW4288050626

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.